title: Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor.
authors.forename: Hiro
authors.initials: H
authors.lastname: Tatetsu
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Matsuno
authors.forename: Noritaka
authors.initials: N
authors.lastname: Takatsu
authors.forename: Hirosada
authors.initials: H
authors.lastname: Miyake
authors.forename: Koyu
authors.initials: K
authors.lastname: Hoshino
authors.forename: Kisato
authors.initials: K
authors.lastname: Nosaka
authors.forename: Kentaro
authors.initials: K
authors.lastname: Horikawa
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hata
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Mitsuya
authors.forename: Norio
authors.initials: N
authors.lastname: Asou
mesh_terms: D015250:Aclarubicin / Q000008:administration & dosage; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
chemical_list: D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D015250:Aclarubicin